139 related articles for article (PubMed ID: 3095954)
1. Electron microscopic study of the cell surface of dibekacin-treated Pseudomonas aeruginosa.
Aonuma S; Ariji F; Oizumi K; Konno K
Tohoku J Exp Med; 1986 Sep; 150(1):69-75. PubMed ID: 3095954
[TBL] [Abstract][Full Text] [Related]
2. Electron microscopy of Pseudomonas aeruginosa treated with sulbenicillin and dibekacin.
Aonuma S; Ariji F; Oizumi K; Konno K
Tohoku J Exp Med; 1987 Jun; 152(2):119-28. PubMed ID: 3114912
[TBL] [Abstract][Full Text] [Related]
3. [Comparative activity of dibekacin and several cephalosporins on Pseudomonas aeruginosa].
Carlone NA; Cuffini AM; Forno-Pizzoglio M; Aragno M
G Batteriol Virol Immunol; 1983; 76(7-12):246-56. PubMed ID: 6099297
[TBL] [Abstract][Full Text] [Related]
4. Comparative in vitro activities of SCE-129, sulbenicillin, gentamicin, and dibekacin against Pseudomonas.
Tsuchiya K; Kondo M
Antimicrob Agents Chemother; 1978 Mar; 13(3):536-9. PubMed ID: 122528
[TBL] [Abstract][Full Text] [Related]
5. [Synergistic effect of new beta-lactam antibiotics, clavulanic acid and dibekacin on pathogenic microorganisms].
Jastalska D; Lupicki W; Zapaśnik M; Pajchel G; Chojnowski W
Pol Tyg Lek; 1984 Oct; 39(43):1415-8. PubMed ID: 6440130
[No Abstract] [Full Text] [Related]
6. Synergistic effects of a macrolide and a cell wall-affecting antibiotic on Pseudomonas aeruginosa in vitro and in vivo. 2. Combined effects of a macrolide with a fosfomycin and an aminoglycoside antibiotic.
Kasai T; Homma JY
J Antibiot (Tokyo); 1982 Jul; 35(7):858-65. PubMed ID: 6816781
[TBL] [Abstract][Full Text] [Related]
7. Cefoxitin: synergism with aminoglycosides in vitro.
Une T; Osada Y; Ogawa H
Arzneimittelforschung; 1981; 31(5):761-4. PubMed ID: 6791664
[TBL] [Abstract][Full Text] [Related]
8. [Combination action of sisomicin, dibekacin and cefotetan, cefotaxime, latamoxef, and cefsulodin against Escherichia coli, Serratia marcescens, and Pseudomonas aeruginosa].
Saito M; Azuma K; Nishino T; Tanino T
Jpn J Antibiot; 1983 Oct; 36(10):2833-43. PubMed ID: 6325746
[TBL] [Abstract][Full Text] [Related]
9. [Studies on synergistic effect of sulbenicillin and dibekacin against gram-negative bacilli (author's transl)].
Tomioka S; Kobayashi Y
Jpn J Antibiot; 1976 Jun; 29(6):597-600. PubMed ID: 822187
[TBL] [Abstract][Full Text] [Related]
10. [Dibekacin--a novel aminoglycoside antibioticl. Antimicrobial activity and parallel resistance in vitro].
Schassan HH; Witt U
Arzneimittelforschung; 1979; 29(2):174-8. PubMed ID: 582126
[TBL] [Abstract][Full Text] [Related]
11. Periplasm, periplasmic spaces, and their relation to bacterial wall structure: novel secretion of selected periplasmic proteins from Pseudomonas aeruginosa.
Beveridge TJ; Kadurugamuwa JL
Microb Drug Resist; 1996; 2(1):1-8. PubMed ID: 9158716
[TBL] [Abstract][Full Text] [Related]
12. The effect of lipopolysaccharide composition on the ultrastructure of Pseudomonas aeruginosa.
Salkinoja-Salonen M; Nurmiaho EL
J Gen Microbiol; 1978 Mar; 105(1):23-8. PubMed ID: 416172
[TBL] [Abstract][Full Text] [Related]
13. Outer surface changes of Pseudomonas aeruginosa in relation to resistance to gentamicin and carbenicillin.
Katsorchis T; Legakis NJ; Shearer B; Genmmata V; Pataryas H
J Med Microbiol; 1985 Jun; 19(3):375-81. PubMed ID: 2989527
[TBL] [Abstract][Full Text] [Related]
14. Synergistic effect of immune gamma-globulin fraction on protection by antibiotic against corneal ulcers in experimental mice infected with Pseudomonas aeruginosa.
Kawaharajo K; Homma JY
Jpn J Exp Med; 1976 Jun; 46(3):155-65. PubMed ID: 822190
[TBL] [Abstract][Full Text] [Related]
15. Amikacin disrupts the cell envelope of Pseudomonas aeruginosa ATCC 9027.
Walker SG; Beveridge TJ
Can J Microbiol; 1988 Jan; 34(1):12-8. PubMed ID: 3132316
[TBL] [Abstract][Full Text] [Related]
16. Ultrastructural study of polymyxin-resistant isolates of Pseudomonas aeruginosa.
Gilleland HE; Murray RG
J Bacteriol; 1976 Jan; 125(1):267-81. PubMed ID: 173706
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and antibacterial activity of 1-N-[(S)-ω-amino-2-hydroxyalkyl] derivatives of dibekacin, 5-deoxydibekacin, 3'-deoxykanamycin A and gentamicin B.
Umemura E; Sakamoto Y; Takahashi Y; Miyake T
J Antibiot (Tokyo); 2015 Jun; 68(6):421-3. PubMed ID: 25712399
[No Abstract] [Full Text] [Related]
18. [Comparative activity of habekacin and 4 other aminoglycosides against gram-negative bacilli. Evolution of resistance].
Reynaud AE; Coude du Foresto B; Derriennic M; Courtieu AL
Pathol Biol (Paris); 1988 May; 36(5):435-8. PubMed ID: 3136424
[TBL] [Abstract][Full Text] [Related]
19. [Comparative in vitro activity of dibekacin, gentamicin and tobramycin on 617 bacterial strains].
Coulet M; Brun Y; Forey F; Fleurette J
Nouv Presse Med; 1982 Nov; 11(46):3391-5. PubMed ID: 7155846
[TBL] [Abstract][Full Text] [Related]
20. Effects of ozone on membrane permeability and ultrastructure in Pseudomonas aeruginosa.
Zhang YQ; Wu QP; Zhang JM; Yang XH
J Appl Microbiol; 2011 Oct; 111(4):1006-15. PubMed ID: 21790913
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
